Rising Global Burden of Gout: Time to Act.
作者信息
Danve Abhijeet, Neogi Tuhina
机构信息
Yale School of Medicine, New Haven, Connecticut.
Boston University School of Medicine, Boston, Massachusetts.
出版信息
Arthritis Rheumatol. 2020 Nov;72(11):1786-1788. doi: 10.1002/art.41453. Epub 2020 Sep 17.
Abstract
摘要
相似文献
1
Rising Global Burden of Gout: Time to Act.全球痛风负担日益加重：是时候采取行动了。
Arthritis Rheumatol. 2020 Nov;72(11):1786-1788. doi: 10.1002/art.41453. Epub 2020 Sep 17.
2
Gout in China, 1990-2017: the Global Burden of Disease Study 2017.中国痛风流行病学研究：1990-2017 年基于全球疾病负担研究 2017 年数据
Public Health. 2021 Feb;191:33-38. doi: 10.1016/j.puhe.2020.06.029. Epub 2021 Jan 19.
3
Prevalence, Incidence, and Years Lived With Disability Due to Gout and Its Attributable Risk Factors for 195 Countries and Territories 1990-2017: A Systematic Analysis of the Global Burden of Disease Study 2017.1990-2017 年全球 195 个国家和地区痛风的患病率、发病率及伤残调整寿命年（因痛风导致的失能）及其归因危险因素分析：基于 2017 年全球疾病负担研究的系统分析
Arthritis Rheumatol. 2020 Nov;72(11):1916-1927. doi: 10.1002/art.41404. Epub 2020 Sep 10.
4
Global, regional and national burden of gout, 1990-2017: a systematic analysis of the Global Burden of Disease Study.全球、区域和国家痛风负担，1990-2017 年：全球疾病负担研究的系统分析。
Rheumatology (Oxford). 2020 Jul 1;59(7):1529-1538. doi: 10.1093/rheumatology/kez476.
5
Pattern and trend of five major musculoskeletal disorders in China from 1990 to 2017: findings from the Global Burden of Disease Study 2017.1990 年至 2017 年中国五大肌肉骨骼疾病的模式和趋势：来自 2017 年全球疾病负担研究的发现。
BMC Med. 2021 Feb 4;19(1):34. doi: 10.1186/s12916-021-01905-w.
6
The global burden of gout: estimates from the Global Burden of Disease 2010 study.全球痛风负担：来自 2010 年全球疾病负担研究的估计。
Ann Rheum Dis. 2014 Aug;73(8):1470-6. doi: 10.1136/annrheumdis-2013-204647. Epub 2014 Mar 3.
7
Burden of gout in the Nordic region, 1990-2015: findings from the Global Burden of Disease Study 2015.1990 - 2015年北欧地区痛风负担：全球疾病负担研究2015的结果
Scand J Rheumatol. 2018 Sep;47(5):410-417. doi: 10.1080/03009742.2017.1405461. Epub 2018 Jan 29.
8
Global epidemiology of gout: prevalence, incidence and risk factors.痛风的全球流行病学：患病率、发病率和危险因素。
Nat Rev Rheumatol. 2015 Nov;11(11):649-62. doi: 10.1038/nrrheum.2015.91. Epub 2015 Jul 7.
9
The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012.加拿大不列颠哥伦比亚省痛风患病率和发病率的上升：2000年至2012年基于人群的趋势
Semin Arthritis Rheum. 2017 Feb;46(4):451-456. doi: 10.1016/j.semarthrit.2016.08.006. Epub 2016 Aug 17.
10
Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990-2013: findings from the Global Burden of Disease Study 2013.1990 - 2013年东地中海区域肌肉骨骼疾病负担：全球疾病负担研究2013的结果
Ann Rheum Dis. 2017 Aug;76(8):1365-1373. doi: 10.1136/annrheumdis-2016-210146. Epub 2017 Feb 16.
引用本文的文献
1
Mitochondrial calcium uniporter promotes MSU crystal-induced inflammation through inducing mitochondrial Ca overload and ubiquitination of SIRT5 protein.线粒体钙单向转运体通过诱导线粒体钙超载和SIRT5蛋白泛素化促进MSU晶体诱导的炎症。
Arthritis Res Ther. 2025 Aug 22;27(1):168. doi: 10.1186/s13075-025-03627-3.
2
Hyperuricemia in ob/ob mice relates to hepatocellular pyruvate metabolism/ xanthine oxidase axis.ob/ob小鼠的高尿酸血症与肝细胞丙酮酸代谢/黄嘌呤氧化酶轴有关。
PLoS One. 2025 Aug 6;20(8):e0328794. doi: 10.1371/journal.pone.0328794. eCollection 2025.
3
Efficacy of different dosages of common uric acid-lowering medications in gout patients: a network meta-analysis of randomized control trials.不同剂量常用降尿酸药物对痛风患者的疗效：一项随机对照试验的网状Meta分析
Front Pharmacol. 2025 Jun 25;16:1565530. doi: 10.3389/fphar.2025.1565530. eCollection 2025.
4
Systematic analysis of gout burden among young adults in China from 1990 to 2021: findings from the global burden of disease study 2021.1990年至2021年中国青年成年人痛风负担的系统分析：全球疾病负担研究2021的结果
Front Public Health. 2025 Jun 9;13:1613801. doi: 10.3389/fpubh.2025.1613801. eCollection 2025.
5
Exploring Therapeutic Potential of Bi-Qi Capsules in Treatment of Gout by Discovering Crucial Drug Targets.通过发现关键药物靶点探索痹祺胶囊治疗痛风的潜在疗效
Pharmaceuticals (Basel). 2025 Apr 24;18(5):618. doi: 10.3390/ph18050618.
6
Quantitative Assessment of Baseline Serum HDL-C to Predict Gout Flares During Urate-Lowering Therapy Initiation: A Prospective Cohort Study.基线血清高密度脂蛋白胆固醇的定量评估以预测降尿酸治疗起始时的痛风发作：一项前瞻性队列研究
J Inflamm Res. 2024 Dec 19;17:11235-11245. doi: 10.2147/JIR.S493376. eCollection 2024.
7
Identification of key genes in gout and atherosclerosis and construction of molecular regulatory networks.痛风和动脉粥样硬化关键基因的鉴定及分子调控网络的构建
Front Cardiovasc Med. 2024 Nov 29;11:1471633. doi: 10.3389/fcvm.2024.1471633. eCollection 2024.
8
Causal relationship between gout and liver cancer: A Mendelian randomization and transcriptome analysis.痛风与肝癌之间的因果关系：一项孟德尔随机化和转录组分析。
Medicine (Baltimore). 2024 Nov 8;103(45):e40299. doi: 10.1097/MD.0000000000040299.
9
Assessment of electronic health literacy and its association with self-management among gout patients: A cross-sectional study.痛风患者电子健康素养评估及其与自我管理的关联：一项横断面研究。
Arch Rheumatol. 2024 Jul 2;39(3):358-367. doi: 10.46497/ArchRheumatol.2024.10397. eCollection 2024 Sep.
10
Support needs of gout patients and suitability of eHealth to address these needs.痛风患者的支持需求以及电子健康满足这些需求的适用性。
Rheumatol Adv Pract. 2024 Oct 4;8(4):rkae125. doi: 10.1093/rap/rkae125. eCollection 2024.
本文引用的文献
1
2020 American College of Rheumatology Guideline for the Management of Gout.2020年美国风湿病学会痛风管理指南
Arthritis Care Res (Hoboken). 2020 Jun;72(6):744-760. doi: 10.1002/acr.24180. Epub 2020 May 11.
2
Cause-Specific Mortality in Gout: Novel Findings of Elevated Risk of Non-Cardiovascular-Related Deaths.痛风患者的特定病因死亡率：非心血管相关死亡风险升高的新发现。
Arthritis Rheumatol. 2019 Nov;71(11):1935-1942. doi: 10.1002/art.41008. Epub 2019 Sep 25.
3
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、地区和国家残疾调整生命年（DALYs）359 种疾病和伤害以及 195 个国家和地区 1990-2017 年的健康期望寿命（HALE）：2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1859-1922. doi: 10.1016/S0140-6736(18)32335-3.
4
Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial.护士主导的护理在教育和参与患者方面的疗效和成本效益，以及针对目标尿酸降低策略与常规护理相比，在痛风中的应用：一项随机对照试验。
Lancet. 2018 Oct 20;392(10156):1403-1412. doi: 10.1016/S0140-6736(18)32158-5.
5
Medication adherence among patients with gout: A systematic review and meta-analysis.痛风患者的药物依从性：系统评价和荟萃分析。
Semin Arthritis Rheum. 2018 Apr;47(5):689-702. doi: 10.1016/j.semarthrit.2017.09.007. Epub 2017 Oct 7.
6
Health Effects of Overweight and Obesity in 195 Countries over 25 Years.25年间195个国家超重和肥胖对健康的影响
N Engl J Med. 2017 Jul 6;377(1):13-27. doi: 10.1056/NEJMoa1614362. Epub 2017 Jun 12.
7
The unclosing premature mortality gap in gout: a general population-based study.痛风患者过早死亡率差距的扩大：一项基于普通人群的研究。
Ann Rheum Dis. 2017 Jul;76(7):1289-1294. doi: 10.1136/annrheumdis-2016-210588. Epub 2017 Jan 25.
8
Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians.急性和复发性痛风管理：美国医师学院临床实践指南。
Ann Intern Med. 2017 Jan 3;166(1):58-68. doi: 10.7326/M16-0570. Epub 2016 Nov 1.
9
The economic burden of gout: A systematic review.痛风的经济负担：系统评价。
Semin Arthritis Rheum. 2015 Aug;45(1):75-80. doi: 10.1016/j.semarthrit.2015.02.004. Epub 2015 Feb 19.
10
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.全球、地区和国家按年龄、性别划分的 240 种死因的全死因和特定死因死亡率，1990-2013 年：2013 年全球疾病负担研究的系统分析。
Lancet. 2015 Jan 10;385(9963):117-71. doi: 10.1016/S0140-6736(14)61682-2. Epub 2014 Dec 18.
Zotero 插件